Shares of Chinese humanoid maker Unitree Robotics have climbed more than 60% since 15 October, closing at 672 yuan on Monday after a JPMorgan double upgrade, even as the company itself warns investors that commercialisation is still in its early stages.
Published 27 October 2026 · 06:07 GMT
Shares of Chinese humanoid maker Unitree Robotics have climbed more than 60% since 15 October, closing at 672 yuan on Monday after a JPMorgan double upgrade, even as the company itself warns investors that commercialisation is still in its early stages. Shares of Unitree Robotics closed at 672 yuan on Monday, 26 October, up 7.7 per cent on the day and up from 405.10 yuan at the close on 15 October. The stock hit the 20 per cent daily trading limit on Friday, 23 October, closing at 624 yuan, and edged down about 1 per cent in Tuesday morning trading.
Shares of Unitree Robotics, the Shanghai-listed maker of humanoid robots, closed at 672 yuan on Monday, 26 October, up 7.7 per cent on the day and up from 405.10 yuan at the close on 15 October; a rise of more than 60 per cent in under two weeks. The stock had already hit the 20 per cent daily trading limit on Friday, closing at 624 yuan, and it edged down about 1 per cent in Tuesday morning trading, paring some of the gain. The rally has lifted Unitree's market value to about 271.8 billion yuan, roughly 40.8 billion dollars.
The immediate trigger, market reports agree, was a double upgrade from JPMorgan, which lifted the stock from 'underweight' to 'overweight' and more than tripled its price target, days after founder Wang Xingxing told partners in Hangzhou that a breakthrough in physical AI could arrive within one to three years.
JPMorgan's note is the hard fact at the centre of the rally. The bank moved Unitree two notches, from 'underweight' to 'overweight', and raised its price target to 995 yuan from 300 yuan; a December 2027 target built, according to an account of the note, on 30 times estimated 2028 price-to-sales. The bank did not raise its 2026 sales assumption, keeping it at 14,163 humanoid units, but lifted its 2027 forecast to 31,701 units from 26,226 and its 2028 forecast to 111,554 from 41,552, with an implied 2028 global market share of 21 per cent, up from 8 per cent.
The reason for the change matters as much as the numbers: JPMorgan had previously judged Unitree too dependent on hardware and too light on software, and revised that view after briefings with Wang and other executives and a review of the humanoid line-up in Hangzhou. The bank also argues that Unitree is one of the few direct listed proxies for embodied AI in China's A-share market, a scarcity that supports a premium while rival listings face tougher scrutiny.
Nothing in the last two weeks proves that the technology is ready. Wang's claim that large AI models could break through in physical AI within one to two years if all goes well, or two to three otherwise, is a forecast from the company's founder, not a demonstrated result; and his further claim, reported by several outlets, that OpenAI's GPT-6 Astra can already direct robots without training has not been independently verified.
Nor do the forecasts settle the commercial question: JPMorgan's own 2026 sales assumption is unchanged, and Unitree itself warned on 21 October that the industry 'is still in the early stages of commercialisation', with uncertainties over technological maturity, downstream demand and the industrial chain. Researchers have also flagged a security flaw that could let audio, video and spatial data leave a robot's servers unnoticed; a risk no rally can price away. Whether Tuesday's small pullback is a pause or the start of a reversal is, for now, unknowable.
Unitree is the purest listed bet on embodied AI; the idea that the models behind chatbots can soon operate machines in the physical world. China has made humanoid robotics a strategic priority, and Unitree, founded in Hangzhou in 2016, is the first humanoid maker to list on mainland China, on Shanghai's STAR Market. Its flagship G1 humanoid costs about 16,000 dollars, far less than many rivals, and unlike some better-known names it already sells robots at scale: it shipped more than 5,500 humanoid units in 2025, the most in the world, on revenue of nearly 1.7 billion yuan.
The contrast with the United States sharpens the point: Tesla has only just begun producing its Optimus robot at Fremont and expects deliveries to outside customers around the end of 2027, while Figure AI partnered with OpenAI in 2024. Morgan Stanley estimates China's humanoid market will reach 2 billion dollars this year and 15 billion by 2030; which is why a single stock's move is read as a verdict on an entire industrial race, and why the recent tumble in AI stocks despite booming demand is the cautionary tale hanging over it.
Strip out the price action and the story is about a metaphor. At Unitree's August listing, Wang said the industry was approaching a 'ChatGPT moment' in embodied intelligence; a point where a robot dropped into an unfamiliar home could complete most tasks from simple voice or text instructions. The Hangzhou conference on 22 October, the company's first partner event in a decade, turned that metaphor into a timetable, and the market priced the timetable.
The danger in that logic is visible in the company's own history: the shares opened at 1,100 yuan on 19 August, 629 per cent above the 150.80 yuan IPO price, then fell steeply enough that even after this rally they remain well below that debut. A stock that can rise 66 per cent in seven sessions has already shown it can fall just as fast, and the abnormal trading that drew a company warning on 20 October, a cumulative deviation above 30 per cent across three sessions, is a reminder that this market moves on narrative first and earnings second, a pattern the Bank of Japan's warning about AI-market risks has already flagged.
The rally is already spilling across the sector. Rival AgiBot launched its Elf G2 Max heavy-duty robot on 26 October, and Chinese market coverage counted 23 robot stocks hitting their daily limits the same day, with institutions leading the buying; one dedicated institutional seat bought 241 million yuan of Unitree on 23 October alone. For competitors, Unitree's scarcity premium cuts both ways: it proves investors will pay for a listed embodied-AI proxy, but it also raises the bar for the next listing, with JPMorgan arguing that tougher scrutiny of commercialisation quality will slow new entrants.
For suppliers of motors, joints and sensors, a credible path to 111,554 units by 2028 would mean orders on a scale the industry has never seen; for buyers, it means the price of waiting is set by a company whose flagship already undercuts rivals. And for anyone watching the trillion-scale reckoning in chip stocks, the question is how long a narrative rally can run before it needs earnings to justify it.
Three things will test the rally. First, whether the shares hold above Friday's 624 yuan limit-up close after Tuesday's early dip. Second, the company's next disclosure: any update on orders, deliveries or the H2-X humanoid unveiled on 21 October will be read against JPMorgan's unchanged 2026 sales assumption of 14,163 units. Third, whether peers follow with their own numbers; AgiBot's launch and the next round of broker notes will show whether this is a Unitree story or a sector repricing. If the breakthrough Wang promises stays on a one-to-three-year timetable, patience is cheap; if it slips, the 995 yuan target will be the first thing the market revisits.
From the United States and Europe, the story reads as a bet on chatbot brains. American coverage frames Unitree as the hardware play on a software breakthrough: if OpenAI's GPT-6 Astra or its successors can direct machines without training, the companies that build bodies, motors and joints capture the value. The Western lens is also the most sceptical about the hardware itself, flagging the reported security flaw and noting that Tesla's Optimus and Figure AI's OpenAI-powered robots are still pre-scale; which is precisely why a company already shipping robots looks, from this angle, like the exception that proves the rule.
From Asia, the story reads as industrial policy meeting market discipline. Chinese state media stress the fundamentals, more than 5,500 humanoid units shipped in 2025, revenue up 48.54 per cent year on year in the first half of 2026, while Chinese business press stresses the warning: Caixin's account leads with valuation risk, and Unitree's own 21 October disclosure cautions that commercialisation is early and uncertain. The Eastern lens asks not whether robots are exciting, but whether a company trading far above its industry average can convert demonstrations into durable orders.
From the Global South, the story reads through access. South African coverage of Unitree's rise has framed it as a 'ChatGPT moment' for embodied intelligence, but the question from this angle is who gets the machines: a G1 at about 16,000 dollars is cheap for a humanoid and still out of reach for most buyers outside wealthy economies, so the first deployments will be in factories and warehouses in China and the West. For the rest of the world, the rally matters less as an investment than as a timetable; for when capable machines, and the jobs they change, actually arrive.
Unitree shares closed at 672 yuan on Monday, 26 October, up 7.7 per cent on the day and up from 405.10 yuan at the close on 15 October; a rise of more than 60 per cent in under two weeks, and more than 65 per cent across seven trading sessions on Caixin's count. The stock hit its 20 per cent daily limit on Friday, closing at 624 yuan.
JPMorgan moved Unitree from 'underweight' to 'overweight' and raised its price target to 995 yuan from 300 yuan after briefings with founder Wang Xingxing and other executives and a review of the humanoid line-up at the Hangzhou conference. The bank had previously judged Unitree too hardware-heavy and too light on software, and now treats it as one of the few direct listed proxies for embodied AI.
Physical AI is the idea that the large models behind chatbots can soon control machines in the real world; letting a robot dropped into an unfamiliar room complete tasks from simple voice or text instructions. If that breakthrough arrives, the companies that build robot bodies, motors and joints capture much of the value, which is why investors are paying a premium for Unitree.
On 21 October, after its shares rose more than 30 per cent across three sessions, Unitree warned that the humanoid robot industry 'is still in the early stages of commercialisation', with uncertainties over technological maturity, downstream demand and the industrial chain. The company urged investors to be mindful of the risks and to make rational investment decisions.
